Neurofenix, a neurological rehabilitation platform that uses sensor technology to improve patient recovery outcomes, has raised $7 million in Series A funding led by AlbionVC, with additional participation by HTH, InHealth Ventures, and existing investors.

The funding will enable Neurofenix to build out its product line and invest in US expansion, including funding US clinical trials.

Neurofenix Raises $7M In Series A Round Led By Albionvc

Description

Company Information

Related People